Graphic showing the first page of the Report "UDI-related Issues in Form 483s: Where Should You Focus Mitigation Efforts?"

Report – UDI - related Issues in Form 483s: Where Should You Focus Mitigation Efforts?

By

Mark Agostino

,

Areas examined in this report:

  • Actionable intelligence on UDI-related 483 observations
  • Observations grouped into categories
Logo of AMGEN
Logo of Abbvie
Logo of AstraZeneca
Logo of Baxter
Logo of Genentech
Logo of Lilly
Logo of Merck
Logo of Philips Healthcare
Logo of UCB
Logo of AMGEN
Logo of Abbvie
Logo of AstraZeneca
Logo of Baxter
Logo of Genentech
Logo of Lilly
Logo of Merck
Logo of Philips Healthcare
Logo of UCB
If you have trouble with the form, please contact events@redica.com.

Access the white paper

If you have trouble with the form, please contact events@redica.com.